Health Care • Biotechnology: Electromedical & Electrotherapeutic Apparatus
$65.99 ▼ -1.13
(-1.68%)
MKT CAP: $2.29B • VOL: 900.1K
52W L $60 52W H $156
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$55
MEDIAN
$74
MEAN
$75
HIGH
$90
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE TMDX TAPE
TMDX // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $79.85 | $75.89 | 2025-02-14 | $60.05 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $83.15 | $77.87 | 2025-02-06 | $62.03 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $75.23 | $72.59 | 2025-01-29 | $63.35 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $67.31 | — | 2025-01-17 | $64.67 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $58.07 | $62.69 | 2025-01-09 | $58.73 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $78.53 | $68.63 | 2024-12-18 | $57.41 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $64.01 | $66.65 | 2024-12-04 | $61.37 | -4.3% | 48% | C |